Warning letterPosted May 27, 2025

FDA warning letter to Sedecal S.A.

CGMP/QSR/Medical Devices/Adulterated

FDA's record ↗

FDA posted a warning letter to Sedecal S.A. on May 27, 2025; the letter is dated May 5, 2025. Subject: CGMP/QSR/Medical Devices/Adulterated. Issuing office: Center for Devices and Radiological Health.

On the record

Company
Sedecal S.A.
Subject
CGMP/QSR/Medical Devices/Adulterated
Issuing office
Center for Devices and Radiological Health
Letter dated
2025-05-05
Posted by FDA
2025-05-27
Source
FDA warning letters ↗

CFR cited

The record cites 5 sections of 21 CFR Parts 806, 820, 1002 and 1020.

The full record

An account shows the violations FDA described and each CFR section it cited.

What a warning letter is

A warning letter is FDA's notice to a company that it found significant violations of federal requirements. FDA asks for a written response, normally within 15 working days. The letter is advisory: it states the agency's position and is not a final agency action.

More

Watch Sedecal S.A

A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.

From FDA warning letters. The record may have changed since it was read.

Approve Suite is not affiliated with FDA, or with Sedecal S.A.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.